Franklin Resources Inc Cytom X Therapeutics, Inc. Transaction History

Franklin Resources Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$1.26 - $1.87 $9,129 - $13,550	-7,246 Reduced 21.26%	26,838 $34,000
Q2 2022 Aug 11, 2022	SELL	$1.53 - $2.89 $25,390 - $47,959	-16,595 Reduced 32.75%	34,084 $62,000
Q4 2021 Feb 11, 2022	SELL	$3.87 - $7.39 $468 - $894	-121 Reduced 0.24%	50,679 $219,000
Q3 2021 Nov 12, 2021	BUY	$4.32 - $6.43 $219,456 - $326,644	50,800 New	50,800 $259,000
Q4 2018 Feb 12, 2019	SELL	$12.69 - $18.61 $4.23 Million - $6.21 Million	-333,576 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$21.38 - $29.68 $1,624 - $2,255	76 Added 0.02%	333,576 $7.63 Million
Q3 2017 Nov 13, 2017	BUY	$13.53 - $18.17 $4.51 Million - $6.06 Million	333,500	333,500 $6.06 Million

50.7M

112K

8.3K

Ticker CTMX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,950,200
Market Cap $69.9M
Description
CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer. The company's product candidates include CX-2009, an antibody drug conjugates (ADC) against CD166, which is in Phase II clinical...

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

Stay updated on Franklin Resources Inc with notifications on news.